Healthcare Trust of America (HTA) 10-Q 29 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 27, 2014
Entity Information [Line Items]	'	'
Entity Registrant Name	'HEALTHCARE TRUST OF AMERICA, INC.	'
Entity Central Index Key	'0001360604	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	238,946,821
Healthcare Trust of America Holdings, LP (HTALP)	'	'
Entity Information [Line Items]	'	'
Entity Registrant Name	'Healthcare Trust of America Holdings, LP	'
Entity Central Index Key	'0001495491	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real estate investments:	'	'
Land	$272,922	$203,001
Building and improvements	2,554,006	2,358,071
Lease intangibles	413,403	411,857
Real estate investments, gross	3,240,331	2,972,929
Accumulated depreciation and amortization	-518,647	-445,938
Real estate investments, net (see Note 2)	2,721,684	2,526,991
Assets held for sale, net	22,930	0
Real estate notes receivable	8,520	28,520
Cash and cash equivalents	18,415	18,081
Restricted cash and escrow deposits	31,329	18,114
Receivables and other assets, net	141,561	110,285
Other intangibles, net	42,362	50,343
Total assets	2,986,801	2,752,334
Liabilities:	'	'
Debt	1,497,136	1,214,241
Accounts payable and accrued liabilities	98,163	82,893
Derivative financial instruments - interest rate swaps	4,127	5,053
Security deposits, prepaid rent and other liabilities	31,935	35,339
Intangible liabilities, net	11,520	11,797
Total liabilities	1,642,881	1,349,323
Commitments and contingencies	'	'
Redeemable noncontrolling interest of limited partners	3,258	3,262
Equity/Partners' Capital:	'	'
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	0	0
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 238,944,761 and 236,880,614 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively	2,389	2,369
Additional paid-in capital	2,147,688	2,126,897
Cumulative dividends in excess of earnings	-820,978	-742,060
Total stockholders’ equity	1,329,099	1,387,206
Noncontrolling interest	11,563	12,543
Total equity	1,340,662	1,399,749
Total liabilities and equity/partners' capital	2,986,801	2,752,334
Healthcare Trust of America Holdings, LP (HTALP)	'	'
Real estate investments:	'	'
Land	272,922	203,001
Building and improvements	2,554,006	2,358,071
Lease intangibles	413,403	411,857
Real estate investments, gross	3,240,331	2,972,929
Accumulated depreciation and amortization	-518,647	-445,938
Real estate investments, net (see Note 2)	2,721,684	2,526,991
Assets held for sale, net	22,930	0
Real estate notes receivable	8,520	28,520
Cash and cash equivalents	18,415	18,081
Restricted cash and escrow deposits	31,329	18,114
Receivables and other assets, net	141,561	110,285
Other intangibles, net	42,362	50,343
Total assets	2,986,801	2,752,334
Liabilities:	'	'
Debt	1,497,136	1,214,241
Accounts payable and accrued liabilities	98,163	82,893
Derivative financial instruments - interest rate swaps	4,127	5,053
Security deposits, prepaid rent and other liabilities	31,935	35,339
Intangible liabilities, net	11,520	11,797
Total liabilities	1,642,881	1,349,323
Commitments and contingencies	'	'
Redeemable noncontrolling interest of limited partners	1,765	1,717
Equity/Partners' Capital:	'	'
Limited partners’ capital, 2,973,998 and 3,052,918 units issued and outstanding as of September 30, 2014 and December 31, 2013, respectively	12,786	13,818
General partners’ capital, 238,944,761 and 236,880,614 units issued and outstanding as of September 30, 2014 and December 31, 2013, respectively	1,329,369	1,387,476
Total partners’ capital	1,342,155	1,401,294
Total liabilities and equity/partners' capital	$2,986,801	$2,752,334

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Equity:	'	'
Preferred stock, par value (usd per share)	$0.01	$0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A	'	'
Equity:	'	'
Common stock, par value (usd per share)	$0.01	$0.01
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	238,944,761	236,880,614
Common stock, shares outstanding	238,944,761	236,880,614
Healthcare Trust of America Holdings, LP (HTALP)	'	'
Partners’ Capital:	'	'
Limited partner's capital, units issued	2,973,998	3,052,918
Limited partner's capital, units outstanding	2,973,998	3,052,918
General partner's capital, units issued	238,944,761	236,880,614
General partner's capital, units outstanding	238,944,761	236,880,614

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended				9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Revenues:	'		'		'		'
Rental income	$95,277		$82,349		$274,675		$235,595
Interest income from real estate notes receivable	257		635		1,834		1,874
Total revenues	95,534		82,984		276,509		237,469
Expenses:	'		'		'		'
Rental	28,526		25,837		85,179		72,435
General and administrative	5,935		5,980		18,137		18,645
Acquisition-related	2,802		1,403		8,647		3,086
Depreciation and amortization	35,802		29,581		104,346		87,725
Listing	0		0		0		4,405
Total expenses	73,065		62,801		216,309		186,296
Income before other income (expense)	22,469		20,183		60,200		51,173
Interest expense:	'		'		'		'
Interest related to derivative financial instruments	-1,433		-1,087		-4,148		-3,448
Net gain (loss) on change in the fair value of derivative financial instruments	2,564		-1,955		-857		8,573
Total interest related to derivative financial instruments, including net change in the fair value of derivative financial instruments	1,131		-3,042		-5,005		5,125
Interest related to debt	-14,119		-12,146		-37,802		-35,704
Gain on sales of real estate	11,766		0		11,766		0
Loss on extinguishment of debt, net	-5,028		0		-4,663		0
Other income	1		10		41		28
Net income	16,220		5,005		24,537		20,622
Net income attributable to noncontrolling interests	-188	[1]	-182	[1]	-358	[1]	-423	[1]
Net income attributable to common stockholders/unitholders	16,032		4,823		24,179		20,199
Earnings per common share/unit - basic	'		'		'		'
Net income attributable to common stockholders/unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Earnings per common share/unit - diluted:	'		'		'		'
Net income attributable to common stockholders/unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Weighted average number of common shares/units outstanding:	'		'		'		'
Basic (in shares/units)	238,968		232,514		238,099		225,132
Diluted (in shares/units)	241,432		235,023		240,608		226,771
Dividends/Distributions declared per common share/unit (in usd per share/unit)	$0.15		$0.14		$0.43		$0.43
Healthcare Trust of America Holdings, LP (HTALP)	'		'		'		'
Revenues:	'		'		'		'
Rental income	95,277		82,349		274,675		235,595
Interest income from real estate notes receivable	257		635		1,834		1,874
Total revenues	95,534		82,984		276,509		237,469
Expenses:	'		'		'		'
Rental	28,526		25,837		85,179		72,435
General and administrative	5,935		5,980		18,137		18,645
Acquisition-related	2,802		1,403		8,647		3,086
Depreciation and amortization	35,802		29,581		104,346		87,725
Listing	0		0		0		4,405
Total expenses	73,065		62,801		216,309		186,296
Income before other income (expense)	22,469		20,183		60,200		51,173
Interest expense:	'		'		'		'
Interest related to derivative financial instruments	-1,433		-1,087		-4,148		-3,448
Net gain (loss) on change in the fair value of derivative financial instruments	2,564		-1,955		-857		8,573
Total interest related to derivative financial instruments, including net change in the fair value of derivative financial instruments	1,131		-3,042		-5,005		5,125
Interest related to debt	-14,119		-12,146		-37,802		-35,704
Gain on sales of real estate	11,766		0		11,766		0
Loss on extinguishment of debt, net	-5,028		0		-4,663		0
Other income	1		10		41		28
Net income	16,220		5,005		24,537		20,622
Net income attributable to noncontrolling interests	-28	[1]	-9	[1]	-106	[1]	-39	[1]
Net income attributable to common stockholders/unitholders	$16,192		$4,996		$24,431		$20,583
Earnings per common share/unit - basic	'		'		'		'
Net income attributable to common stockholders/unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Earnings per common share/unit - diluted:	'		'		'		'
Net income attributable to common stockholders/unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Weighted average number of common shares/units outstanding:	'		'		'		'
Basic (in shares/units)	241,948		235,570		241,124		228,188
Diluted (in shares/units)	241,948		235,570		241,124		228,188
Dividends/Distributions declared per common share/unit (in usd per share/unit)	$0.15		$0.14		$0.43		$0.43
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Equity (USD $)	Total	Class A	Common Stock	Common Stock	Common Stock	Additional Paid-In Capital	Cumulative Dividends in Excess of Earnings	Total Stockholders’ Equity	Noncontrolling Interest
In Thousands, except Share data, unless otherwise specified	USD ($)		USD ($)	Class A	Class B	USD ($)	USD ($)	USD ($)	USD ($)
Beginning balance at Dec. 31, 2012	$1,264,595	'	$2,147	'	'	$1,885,836	($633,717)	$1,254,266	$10,329
Beginning balance, shares at Dec. 31, 2012	'	'	'	100,086,000	114,566,000	'	'	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'	'
Issuance of common stock (in shares)	'	'	'	20,707,000	'	'	'	'	'
Issuance of common stock	228,306	'	207	'	'	228,099	'	228,306	'
Share-based award transactions, net (in shares)	'	'	'	427,000	-15,000	'	'	'	'
Share-based award transactions, net	5,129	'	4	'	'	1,948	'	1,952	3,177
Repurchase and cancellation of common stock (in shares)	'	'	'	-28,000	'	'	'	'	'
Repurchase and cancellation of common stock	-287	'	0	'	'	-287	'	-287	'
Conversion	'	'	'	57,283,000	-57,283,000	'	'	'	'
Dividends	-99,584	'	'	'	'	'	-98,630	-98,630	-954
Net income	20,552	'	'	'	'	'	20,199	20,199	353
Ending balance at Sep. 30, 2013	1,418,711	'	2,358	'	'	2,115,596	-712,148	1,405,806	12,905
Ending balance, shares at Sep. 30, 2013	'	'	'	178,475,000	57,268,000	'	'	'	'
Beginning balance at Dec. 31, 2013	1,399,749	'	2,369	'	'	2,126,897	-742,060	1,387,206	12,543
Beginning balance, shares at Dec. 31, 2013	'	236,880,614	'	236,880,000	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'	'
Issuance of common stock (in shares)	'	'	'	1,542,000	'	'	'	'	'
Issuance of common stock	17,742	'	16	'	'	17,726	'	17,742	'
Share-based award transactions, net (in shares)	'	'	'	508,000	'	'	'	'	'
Share-based award transactions, net	3,279	'	5	'	'	3,274	'	3,279	0
Repurchase and cancellation of common stock (in shares)	'	'	'	-58,000	'	'	'	'	'
Repurchase and cancellation of common stock	-572	'	-1	'	'	-571	'	-572	'
Redemption of noncontrolling interest (in shares)	'	'	'	73,000	'	'	'	'	'
Redemption of noncontrolling interest	'	'	'	'	'	362	'	362	-362
Dividends	-103,951	'	'	'	'	'	-103,097	-103,097	-854
Net income	24,415	'	'	'	'	'	24,179	24,179	236
Ending balance at Sep. 30, 2014	$1,340,662	'	$2,389	'	'	$2,147,688	($820,978)	$1,329,099	$11,563
Ending balance, shares at Sep. 30, 2014	'	238,944,761	'	238,945,000	0	'	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Changes In Partners' Capital (USD $)	Total	Healthcare Trust of America Holdings, LP (HTALP)	Healthcare Trust of America Holdings, LP (HTALP)	Healthcare Trust of America Holdings, LP (HTALP)
In Thousands, unless otherwise specified			General Partner	Limited Partner
Balance as of beginning of period at Dec. 31, 2012	'	$1,266,199	$1,254,536	$11,663
Balance as of beginning of period (in units) at Dec. 31, 2012	'	'	214,652	3,056
Increase (Decrease) in Partners' Capital [Roll Forward]	'	'	'	'
Issuance of general partner units (in units)	'	'	20,707	'
Issuance of general partner units	'	228,306	228,306	'
Share-based award transactions, net (in units)	'	'	412	-2
Share-based award transactions, net	'	5,129	1,952	3,177
Redemptions of general partner units	'	'	-28	'
Redemptions of general partner units	'	-287	-287	'
Distributions	'	-99,651	-98,630	-1,021
Net income attributable to common unitholders	20,199	20,583	20,199	384
Balance as of end of period at Sep. 30, 2013	'	1,420,279	1,406,076	14,203
Balance as of end of period (in units) at Sep. 30, 2013	'	'	235,743	3,054
Balance as of beginning of period at Jun. 30, 2013	'	'	'	'
Increase (Decrease) in Partners' Capital [Roll Forward]	'	'	'	'
Net income attributable to common unitholders	4,823	4,996	'	'
Balance as of end of period at Sep. 30, 2013	'	1,420,279	'	'
Balance as of beginning of period at Dec. 31, 2013	'	1,401,294	1,387,476	13,818
Balance as of beginning of period (in units) at Dec. 31, 2013	'	'	236,880	3,053
Increase (Decrease) in Partners' Capital [Roll Forward]	'	'	'	'
Issuance of general partner units (in units)	'	'	1,542	'
Issuance of general partner units	'	17,742	17,742	'
Share-based award transactions, net (in units)	'	'	508	-6
Share-based award transactions, net	'	3,279	3,279	'
Redemptions of general partner units	'	'	-58	'
Redemptions of general partner units	'	-572	-572	'
Redemption of limited partner units (in units)	'	'	73	-73
Redemption of limited partner units	'	0	362	-362
Distributions	'	-104,019	-103,097	-922
Net income attributable to common unitholders	24,179	24,431	24,179	252
Balance as of end of period at Sep. 30, 2014	'	1,342,155	1,329,369	12,786
Balance as of end of period (in units) at Sep. 30, 2014	'	'	238,945	2,974
Balance as of beginning of period at Jun. 30, 2014	'	'	'	'
Increase (Decrease) in Partners' Capital [Roll Forward]	'	'	'	'
Net income attributable to common unitholders	16,032	16,192	'	'
Balance as of end of period at Sep. 30, 2014	'	$1,342,155	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income	$24,537	$20,622
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation, amortization and other	101,168	86,654
Share-based compensation expense	3,279	5,129
Bad debt expense	485	107
Gain on sales of real estate	-11,766	0
Loss on extinguishment of debt, net	4,663	0
Change in fair value of derivative financial instruments	857	-8,573
Changes in operating assets and liabilities:	'	'
Receivables and other assets, net	-4,443	-13,569
Accounts payable and accrued liabilities	13,212	21,928
Security deposits, prepaid rent and other liabilities	-2,442	6,377
Net cash provided by operating activities	129,550	118,675
Cash flows from investing activities:	'	'
Acquisition of real estate operating properties	-229,644	-223,839
Proceeds from sales of real estate	40,148	0
Capital expenditures	-24,167	-16,486
Collection of real estate notes receivable	20,000	0
Issuance of real estate notes receivable	0	-8,520
Restricted cash, escrow deposits and other assets	-29,318	-2,446
Net cash used in investing activities	-222,981	-251,291
Cash flows from financing activities:	'	'
Proceeds from unsecured senior notes	297,615	297,558
Borrowings on unsecured revolving credit facility	213,000	103,000
Payments on unsecured revolving credit facility	-233,000	-175,000
Payments on secured real estate term loan and mortgage loans	-90,389	-155,302
Deferred financing costs	-6,093	-3,471
Derivative financial instrument termination payments	0	-1,195
Security deposits	-1,245	967
Proceeds from issuance of common stock, net	18,016	229,498
Repurchase and cancellation of common stock	-572	-287
Dividends	-102,506	-95,597
Payment on earnout liability	0	-92
Distributions to noncontrolling interest of limited partners	-1,061	-1,238
Net cash provided by financing activities	93,765	198,841
Net change in cash and cash equivalents	334	66,225
Cash and cash equivalents - beginning of period	18,081	15,956
Cash and cash equivalents - end of period	18,415	82,181
Healthcare Trust of America Holdings, LP (HTALP)	'	'
Cash flows from operating activities:	'	'
Net income	24,537	20,622
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation, amortization and other	101,168	86,654
Share-based compensation expense	3,279	5,129
Bad debt expense	485	107
Gain on sales of real estate	-11,766	0
Loss on extinguishment of debt, net	4,663	0
Change in fair value of derivative financial instruments	857	-8,573
Changes in operating assets and liabilities:	'	'
Receivables and other assets, net	-4,443	-13,569
Accounts payable and accrued liabilities	13,212	21,928
Security deposits, prepaid rent and other liabilities	-2,442	6,377
Net cash provided by operating activities	129,550	118,675
Cash flows from investing activities:	'	'
Acquisition of real estate operating properties	-229,644	-223,839
Proceeds from sales of real estate	40,148	0
Capital expenditures	-24,167	-16,486
Collection of real estate notes receivable	20,000	0
Issuance of real estate notes receivable	0	-8,520
Restricted cash, escrow deposits and other assets	-29,318	-2,446
Net cash used in investing activities	-222,981	-251,291
Cash flows from financing activities:	'	'
Proceeds from unsecured senior notes	297,615	297,558
Borrowings on unsecured revolving credit facility	213,000	103,000
Payments on unsecured revolving credit facility	-233,000	-175,000
Payments on secured real estate term loan and mortgage loans	-90,389	-155,302
Deferred financing costs	-6,093	-3,471
Derivative financial instrument termination payments	0	-1,195
Security deposits	-1,245	967
Proceeds from issuance of general partner units, net	18,016	229,498
Repurchase and cancellation of general partner units	-572	-287
Distributions to general partner	-102,506	-95,597
Payment on earnout liability	0	-92
Distributions to limited partners and redeemable noncontrolling interests	-1,061	-1,238
Net cash provided by financing activities	93,765	198,841
Net change in cash and cash equivalents	334	66,225
Cash and cash equivalents - beginning of period	18,081	15,956
Cash and cash equivalents - end of period	$18,415	$82,181

Organization_and_Description_o

Organization and Description of Business	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Description of Business	'
	Organization and Description of Business
	HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership. As of September 30, 2014, HTA owned a 99.0% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debts of HTALP. HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity.
	HTA is one of the largest publicly-traded REITs focused on medical office buildings in the United States based on gross leasable area (“GLA”). We are primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on, or aligned with, campuses of nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) seek internal growth through proactive asset management, leasing and property management oversight, (ii) target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.
	We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of approximately $3.3 billion through September 30, 2014.
	Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”), in all material respects, and have been consistently applied in preparing our accompanying condensed consolidated financial statements.
	Basis of Presentation
	Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
	Interim Unaudited Financial Data
	Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2013 Annual Report on Form 10-K.
	Variable Interest Entities
	As of September 30, 2014, our condensed consolidated financial statements include four VIEs, which we were deemed to be the primary beneficiary. All of the VIEs were established during the third quarter of 2014 to facilitate potential Section 1031 Exchanges. The impact of consolidating the VIEs increased our total real estate assets by $72.2 million, but had no impact on our total assets.
	Real Estate Investments
	Depreciation expense of buildings and improvements for the three months ended September 30, 2014 and 2013 was $22.6 million and $18.9 million, respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2014 and 2013 was $65.0 million and $55.6 million, respectively.
	Noncontrolling Interests
	HTA’s net income attributable to noncontrolling interests in the accompanying condensed consolidated statements of operations relate to both noncontrolling interest reflected within equity and redeemable noncontrolling interest of limited partners reflected outside of equity in the accompanying condensed consolidated balance sheets. Limited partner units, including LTIP awards, are accounted for as partners’ capital in HTALP’s accompanying condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s accompanying condensed consolidated balance sheets.
	Redeemable noncontrolling interests relate to the interests in our consolidated entities that are not wholly owned by us. As these redeemable noncontrolling interests provide for redemption features not solely within our control, we classify such interests outside of permanent equity or partners’ capital.
	Recently Issued or Adopted Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Updated (“ASU”) 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) which changes the requirements for reporting discontinued operations. ASU 2014-08 changes the threshold for disclosing discontinued operations and the related disclosure requirements. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or majority equity investment, should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. The guidance will be applied prospectively to new disposals and new classifications of disposal groups held for sale after the effective date. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014 with early adoption permitted but only for disposals or classifications as held for sale which have not been reported in financial statements previously issued or available for issuance. We adopted ASU 2014-08 as of January 1, 2014 and believe future sales of our individual operating properties will no longer qualify as discontinued operations.
	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. ASU 2014-09 is effective for the first interim period within annual reporting periods beginning after December 15, 2016, and early adoption is not permitted. We are still evaluating the impact of adopting ASU 2014-09 on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, Compensation - Stock Compensation (Topic 718). ASU 2014-12 requires that a performance target requisite service period be treated as a performance condition and, as a result, this type of performance condition may delay expense recognition until achievement of the performance target is probable. ASU 2014-12 is effective for reporting periods beginning after December 15, 2015, and early adoption is permitted. We will adopt ASU 2014-12 effective January 1, 2016 and it is not anticipated to have a material impact on our financial statements.

Business_Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combinations	'
	Business Combinations
	For the nine months ended September 30, 2014, we had five acquisitions for an aggregate purchase price of $317.6 million. We incurred $5.6 million of costs attributable to these acquisitions. As part of the acquisitions, we assumed mortgage loans with an aggregate fair value of $91.5 million.
	Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for the 2014 acquisitions are set forth below in the aggregate (in thousands):
	2014 Acquisitions		Total
	Land		$	70,609
	Building and improvements		227,458
	Below market leasehold interests		98
	Above market leases		1,708
	In place leases		22,233
	Below market leases		(953		)
	Above market debt, net		(2,664		)
	Net assets acquired		318,489
	Other, net		(939		)
	Aggregate purchase price		$	317,550
	The weighted average lives of the above acquired intangible assets and liabilities were 9.1 years and 8.5 years, respectively.
	The following is a brief description of each of the acquisitions.
	•	In June 2014, we acquired a portfolio of medical office buildings located in Boston, Massachusetts; Miami, Florida; and Baltimore, Maryland, for an aggregate purchase price of $200.0 million.
	•	In June 2014, we acquired a medical office building located in Raleigh, North Carolina for $11.5 million.
	•	In August 2014, we acquired a portfolio of medical office buildings located in White Plains, New York for $64.0 million.
	•	In August 2014, we acquired a medical office building located in Charleston, South Carolina for $24.8 million.
	•	In September 2014, we acquired a medical office building located in Clearwater, Florida for $17.3 million.
	The acquisitions completed during the nine months ended September 30, 2013 were determined to be individually not significant, but material on a collective basis. The allocations for these acquisitions are set forth below in the aggregate (in thousands):
	2013 Acquisitions		Total
	Land		$	13,415
	Building and improvements		175,039
	Below market leasehold interests		1,836
	Above market leases		1,987
	In place leases		32,205
	Tenant relationships		16,541
	Below market leases		(1,167		)
	Above market debt		(241		)
	Net assets acquired		239,615
	Other, net		2,299
	Aggregate purchase price		$	241,914
	The weighted average lives of the above acquired intangible assets and liabilities were 7.4 years and 5.7 years, respectively.

Dispositions_and_Assets_Held_f

Dispositions and Assets Held for Sale	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Dispositions and Assets Held for Sale	'
	Dispositions and Assets Held for Sale
	During the three months ended September 30, 2014, we had two dispositions of portfolios of medical office buildings for an aggregate gross sales price of $42.0 million resulting in a gain of $11.8 million.  In addition, we entered into a purchase and sale agreement as the seller and received a non-refundable deposit from the purchaser for the sale of an additional portfolio of medical office buildings for gross proceeds of $40.9 million.  This portfolio, which includes $18.9 million of real estate investments and $3.1 million of other intangibles, was reclassified to assets held for sale during the third quarter of 2014.  Our sale of these medical office buildings closed in October 2014 resulting in a gain of approximately $16 million.
	During 2013, we had one property within our portfolio that met the criteria for classification as held for sale. Accordingly, we presented the assets and liabilities separately and included the results of operations within discontinued operations for all periods presented. Additionally, we ceased recording depreciation and amortization following the held for sale designation. During the quarter ended March 31, 2014, we determined that it was appropriate to reclassify the property out of held for sale in our condensed consolidated balance sheets and to include the results of operations within the results of operations of our operating properties in our condensed consolidated statements of operations for all periods presented as the property no longer met the criteria for classification as held for sale. We measured the property to be reclassified at the lower of its carrying value before it was classified as held for sale (adjusted for any depreciation and amortization expense that would have been recognized had the property been continuously classified as held and used) or its fair value at the date of the subsequent decision not to sell. As such, during the quarter ended March 31, 2014, we recorded $0.8 million of depreciation and amortization expense which represents the depreciation and amortization on the property that was not recorded when it was classified as held for sale.

Real_Estate_Notes_Receivable

Real Estate Notes Receivable	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]	'
Real Estate Notes Receivable	'
	Real Estate Notes Receivable
	As of December 31, 2013, we had $28.5 million in real estate notes receivable secured by medical office buildings. During the nine months ended September 30, 2014, $20.0 million of our real estate notes receivable were repaid by the borrower. As of September 30, 2014, we had two promissory notes outstanding totaling an aggregate amount of $8.5 million. Each of the promissory notes has an interest rate of 7.0% per annum and mature on October 1, 2016. We are advised by the property owner/borrower that the properties are being actively marketed for sale and the outstanding notes will be repaid upon sale.
	We monitor the credit quality of our real estate notes receivable on an ongoing basis by tracking possible credit quality indicators. As of September 30, 2014, our real estate notes receivable are current and we have not provided for any allowance for losses or recorded any impairments. We made no purchases or sales of real estate notes receivable during the nine months ended September 30, 2014.

Intangibles_Assets_and_Liabili

Intangibles Assets and Liabilities	9 Months Ended
	Sep. 30, 2014
Identified Intangibles, Net [Abstract]	'
Intangibles Assets and Liabilities	'
	Intangible Assets and Liabilities
	Intangible assets and liabilities consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands, except weighted average remaining amortization period):
		September 30, 2014					December 31, 2013
		Balance			Weighted Average Remaining Amortization Period in Years		Balance				Weighted Average Remaining Amortization Period in Years	Balance Sheet Classification
	Assets:
	In place leases	$	225,023		8.6		$	213,338			8.8	Lease intangibles
	Tenant relationships	188,380			10.4		198,519				10.5	Lease intangibles
	Above market leases	26,566			5.8		26,799				6.3	Other intangibles, net
	Below market leasehold interests	31,393			67.7		37,640				68.9	Other intangibles, net
		471,362					476,296
	Accumulated amortization	(172,708		)			(151,860		)
	Total	$	298,654		15.4		$	324,436			15.9
	Liabilities:
	Below market leases	$	13,999		12.1		$	13,989			12.4	Intangible liabilities, net
	Above market leasehold interests	3,827			32.4		3,827				33.1	Intangible liabilities, net
		17,826					17,816
	Accumulated amortization	(6,306		)			(6,019		)
	Total	$	11,520		18.1		$	11,797			18.4
	The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended September 30,							Nine Months Ended September 30,
		2014			2013				2014			2013
	Amortization recorded against rental income related to above or below market leases	$	505		$	417			$	1,534		$	1,298
	Rental expense related to above or below market leasehold interests	112			89				358			278
	Amortization expense related to in place leases and tenant relationships	12,066			9,955				36,247			29,970

Receivables_and_Other_Assets

Receivables and Other Assets	9 Months Ended
	Sep. 30, 2014
Receivables and Other Assets [Abstract]	'
Receivables and Other Assets	'
	Receivables and Other Assets
	Receivables and other assets consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands):
		September 30, 2014		December 31, 2013
	Accounts and other receivables, net	$	23,749	$	22,847
	Tenant note receivable	3,080		3,173
	Deferred financing costs, net	12,418		10,921
	Deferred leasing costs, net	16,616		13,500
	Lease inducements, net	807		771
	Straight-line rent receivables, net	54,057		47,317
	Prepaid expenses, deposits, equipment and other, net	27,544		6,683
	Derivative financial instruments - interest rate swaps	3,290		5,073
	Total	$	141,561	$	110,285
	The following is a summary of amortization of deferred leasing costs, deferred financing costs, and lease inducements for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Amortization expense related to deferred leasing costs	$	957	$	686	$	2,646	$	1,862
	Interest expense related to deferred financing costs	724		805		2,319		3,084
	Amortization recorded against rental income related to lease inducements	50		56		168		173

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt	'
	Debt
	Debt consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands):
		September 30, 2014			December 31, 2013
	Unsecured revolving credit facility	$	35,000		$	55,000
	Unsecured term loans	455,000			455,000
	Unsecured senior notes	600,000			300,000
	Fixed rate mortgages	379,196			373,751
	Variable rate mortgages	29,590			29,925
		1,498,786			1,213,676
	Net premium (discount)	(1,650		)	565
	Total	$	1,497,136		$	1,214,241
	Unsecured Credit Agreement
	Unsecured Revolving Credit Facility
	HTA’s and HTALP’s $650.0 million unsecured revolving credit facility matures on March 29, 2016 and includes a one-year extension, at the option of the borrower, subject to certain conditions. The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the credit facility. The maximum principal amount of the credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility.
	Borrowings under the $650.0 million unsecured revolving credit facility accrue interest equal to adjusted LIBOR, plus a margin ranging from 1.10% to 1.75% per annum based on our credit rating. We also pay a facility fee ranging from 0.20% to 0.50% per annum on the aggregate commitments under the unsecured revolving credit facility. As of September 30, 2014, the margin associated with our borrowings was 1.30% per annum and the facility fee was 0.25% per annum.
	Unsecured Term Loan
	On January 7, 2014, HTA and HTALP executed an amendment to the unsecured credit agreement that decreased the interest rate on the unsecured term loan and extended the maturity date. Borrowings under the $300.0 million unsecured term loan accrue interest equal to adjusted LIBOR, plus a margin ranging from 1.05% to 1.95% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2014 was 1.20% per annum. We have interest rate swaps in place that fix the interest rate at 2.30% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2018 and includes a one-year extension, at the option of the borrower, subject to certain conditions.
	$155.0 Million Unsecured Term Loan
	On July 20, 2012, HTALP entered into a $155.0 million unsecured term loan that is guaranteed by HTA. The loan matures on July 19, 2019 and the interest rate thereon is equal to LIBOR, plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2014 was 1.70% per annum. We have interest rate swaps in place that fix the interest rate at 2.99% per annum, based on our current credit rating. The maximum principal amount under this unsecured term loan may be increased by us, subject to such additional financing being provided by our existing lender.
	$300.0 Million Unsecured Senior Notes due 2023
	On March 28, 2013, HTALP issued $300.0 million of unsecured senior notes guaranteed by HTA that mature on April 15, 2023. The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.186% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum.
	$300.0 Million Unsecured Senior Notes due 2021
	On June 26, 2014, HTALP issued $300.0 million of unsecured senior notes guaranteed by HTA that mature on July 15, 2021. The unsecured senior notes are registered under the Securities Act, bear interest at 3.375% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.205% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum.
	Fixed and Variable Rate Mortgages
	As of September 30, 2014, HTALP and its subsidiaries had fixed and variable rate mortgages with interest rates ranging from 1.60% to 12.75% per annum and a weighted average interest rate of 5.31% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage, the weighted average interest rate was 5.56% per annum. During 2014, we assumed certain fixed rate mortgage loans, see Note 3.
	Future Debt Maturities
	The following table summarizes the debt maturities and scheduled principal repayments as of September 30, 2014 (in thousands):
	Year	Amount
	2014	$	2,105
	2015	73,454
	2016	104,625
	2017	102,744
	2018	314,881
	Thereafter	900,977
	Total	$	1,498,786
	The above scheduled debt maturities do not include the extensions available to us under the unsecured credit agreement as discussed above.
	We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us, and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios, and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of September 30, 2014, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.

Derivative_Financial_Instrumen

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	Derivative Financial Instruments
	The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2014 (in thousands):
	Notional Amount			Index		Rate			Fair Value				Instrument		Maturity
	$	200,000		LIBOR		1.23	%		$	(1,404	)		Swap		3/29/17
	100,000			LIBOR		0.86			(465		)		Swap		6/15/16
	50,000			LIBOR		1.39			812				Swap		7/17/19
	105,000			LIBOR		1.24			2,478				Swap		7/17/19
	27,062			LIBOR		4.98			(2,258		)		Swap		5/1/20
	The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2013 (in thousands):
	Notional Amount			Index		Rate			Fair Value				Instrument		Maturity
	$	200,000		LIBOR		1.23	%		$	(2,078	)		Swap		3/29/17
	100,000			LIBOR		0.86			(729		)		Swap		6/15/16
	50,000			LIBOR		1.39			1,350				Swap		7/17/19
	105,000			LIBOR		1.24			3,723				Swap		7/17/19
	27,618			LIBOR		4.98			(2,246		)		Swap		5/1/20
	As of September 30, 2014 and December 31, 2013, the gross fair value of our derivative financial instruments was as follows (in thousands):
			Asset Derivatives									Liability Derivatives
				Fair Value										Fair Value
	Derivatives Not Designated as Hedging Instruments:		Balance Sheet	30-Sep-14				31-Dec-13				Balance Sheet		30-Sep-14			31-Dec-13
			Location									Location
	Interest rate swaps		Receivables and other assets	$	3,290			$	5,073			Derivative financial instruments		$	4,127		$	5,053
	There were no derivatives offset in our accompanying condensed consolidated balance sheets as of September 30, 2014 and December 31, 2013. As of September 30, 2014 and December 31, 2013, we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands):
		30-Sep-14											31-Dec-13
		Gross Amounts			Amounts Subject to Enforceable Master Netting Arrangements				Net Amounts				Gross Amounts			Amounts Subject to Enforceable Master Netting Arrangements			Net Amounts
	Asset derivatives	$	3,290		$	(1,404	)		$	1,886			$	5,073		$	(2,078	)	$	2,995
	Liability derivatives	4,127			(1,404		)		2,723				5,053			(2,078		)	2,975
	We have agreements with each of our interest rate swap derivative counterparties that contain a provision whereby if we default on certain of our unsecured indebtedness, then our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of September 30, 2014, there have been no termination events or events of default related to our interest rate swaps.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Litigation
	We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material effect on our condensed consolidated financial position, results of operations or cash flows.
	Environmental Matters
	We follow the policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our condensed consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability at our properties that we believe would require additional disclosure or the recording of a loss contingency.
	Other
	Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our opinion, these matters are not expected to have a material effect on our condensed consolidated financial position, results of operations or cash flows.

Stockholders_Equity_and_Partne

Stockholders' Equity and Partners' Capital	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Stockholders' Equity and Partners' Capital	'
	Stockholders’ Equity and Partners’ Capital
	HTALP’s partnership agreement provides that it will distribute cash flows from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Except for certain LTIP units that have not vested, dividend distributions are made such that a holder of one partnership unit will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units.
	Common Stock Offerings
	On February 28, 2014, HTA amended the at-the-market (“ATM”) offering program of its common stock with an aggregate sales price of up to $300.0 million primarily to add sales agents to the program. During the nine months ended September 30, 2014, HTA issued and sold 1,541,715 shares of common stock, at an average price of $11.86 per share and, as of September 30, 2014, $281.7 million remained available for issuance under the ATM.
	Common Stock Dividends
	See condensed consolidated statements of operations for the dividends declared during the three and nine months ended September 30, 2014 and 2013. On October 28, 2014, HTA declared a quarterly cash dividend of $0.145 per share to be paid on January 6, 2015 to stockholders of record of its common stock on December 29, 2014.
	Incentive Plan
	HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors or the Compensation Committee. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 10,000,000. As of September 30, 2014, there were 4,594,200 awards available for grant under the Plan.
	LTIP Units
	Awards under the LTIP consist of Series C units in HTALP, and are subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units are converted into common units of HTALP, which may be converted into shares of HTA’s common stock. For the three and nine months ended September 30, 2013, we recognized compensation expense related to LTIP awards of $0.0 million and $3.1 million, respectively, which was recorded in listing expenses. The LTIP awards were fully expensed in 2013, except for approximately $4.5 million of expense associated with 450,000 units that will only vest in the event of a change in control. We will not recognize any expense associated with these units until such time as a change in control event occurs or is probable.
	The following is a summary of the activity in our LTIP units during 2014:
		LTIP Units		Weighted
				Average Grant
				Date Fair Value
	Balance as of December 31, 2013	516,500		$	9.43
	Granted	—		—
	Vested	—		—
	Forfeited	(6,020	)	5.62
	Balance as of September 30, 2014	510,480		$	9.47
	Restricted Common Stock
	For the three and nine months ended September 30, 2014, we recognized compensation expense of $1.0 million and $3.3 million, respectively, which was recorded in general and administrative expenses. For the three months ended September 30, 2013, we recognized compensation expense of $0.5 million, which was recorded in general and administrative expenses. For the nine months ended September 30, 2013, we recognized compensation expense of $2.0 million, of which $1.4 million was recorded in general and administrative expenses and $0.6 million was recorded in listing expenses.
	As of September 30, 2014, there was approximately $5.2 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 2.0 years.
	The following is a summary of the activity in our restricted common stock during 2014:
		Restricted Common Stock		Weighted
				Average Grant
				Date Fair Value
	Balance as of December 31, 2013	641,000		$	10.34
	Granted	563,200		10.21
	Vested	(148,000	)	10.07
	Forfeited	(55,600	)	9.96
	Balance as of September 30, 2014	1,000,600		$	10.46

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Financial Instruments Reported at Fair Value
	The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2014, aggregated by the applicable Level in the fair value hierarchy (in thousands):
			Quoted Prices in			Significant Other			Significant			Total
			Active Markets for			Observable Inputs			Unobservable Inputs
			Identical Assets			(Level 2)			(Level 3)
			and Liabilities
			(Level 1 )
	Assets:
	Derivative financial instruments		$	—		$	3,290		$	—		$	3,290
	Liabilities:
	Derivative financial instruments		$	—		$	4,127		$	—		$	4,127
	The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2013, aggregated by the applicable Level in the fair value hierarchy (in thousands):
			Quoted Prices in			Significant Other			Significant			Total
			Active Markets for			Observable Inputs			Unobservable Inputs
			Identical Assets			(Level 2)			(Level 3)
			and Liabilities
			(Level 1 )
	Assets:
	Derivative financial instruments		$	—		$	5,073		$	—		$	5,073
	Liabilities:
	Derivative financial instruments		$	—		$	5,053		$	—		$	5,053
	There have been no transfers of assets or liabilities between Levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.
	Financial Instruments Disclosed at Fair Value
	We consider the carrying values of cash and cash equivalents, accounts and other receivables, restricted cash and escrow deposits, and accounts payable and accrued liabilities to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The fair value of the real estate notes receivable and tenant note receivable are estimated by discounting the expected cash flow on the notes at current rates for loans with similar maturities. The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities. The following table sets forth the carrying value and fair value of our real estate notes receivable, tenant note receivable and debt (in thousands):
				September 30, 2014						December 31, 2013
		Fair Value Level		Carrying Amount			Fair Value			Carrying Amount			Fair Value
	Real estate notes receivable	2		$	8,520		$	8,520		$	28,520		$	28,520
	Tenant note receivable	2		3,080			3,028			3,173			3,013
	Debt	2		1,497,136			1,509,761			1,214,241			1,237,699

Per_Share_Data_of_HTA

Per Share Data of HTA	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Per Share Data of HTA	'
	Per Share Data of HTA
	HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and nine months ended September 30, 2014 and 2013, all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA common stock for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Numerator:
	Net income	$	16,220		$	5,005		$	24,537		$	20,622
	Net income attributable to noncontrolling interests	(188		)	(182		)	(358		)	(423		)
	Net income attributable to common stockholders	$	16,032		$	4,823		$	24,179		$	20,199
	Denominator:
	Weighted average number of shares outstanding - basic	238,968			232,514			238,099			225,132
	Dilutive shares	2,464			2,509			2,509			1,639
	Weighted average number of shares outstanding - diluted	241,432			235,023			240,608			226,771
	Earnings per common share - basic
	Net income attributable to common stockholders	$	0.07		$	0.02		$	0.1		$	0.09
	Earnings per common share - diluted
	Net income attributable to common stockholders	$	0.07		$	0.02		$	0.1		$	0.09

Per_Unit_Data_of_HTALP

Per Unit Data of HTALP	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Per Unit Data of HTALP	'
	Per Unit Data of HTALP
	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per unit data):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Numerator:
	Net income	$	16,220		$	5,005		$	24,537		$	20,622
	Net income attributable to noncontrolling interests	(28		)	(9		)	(106		)	(39		)
	Net income attributable to common unitholders	$	16,192		$	4,996		$	24,431		$	20,583
	Denominator:
	Weighted average number of units outstanding - basic	241,948			235,570			241,124			228,188
	Dilutive units	—			—			—			—
	Weighted average number of units outstanding - diluted	241,948			235,570			241,124			228,188
	Earnings per common unit - basic:
	Net income attributable to common unitholders	$	0.07		$	0.02		$	0.1		$	0.09
	Earnings per common unit - diluted:
	Net income attributable to common unitholders	$	0.07		$	0.02		$	0.1		$	0.09

Supplemental_Cash_Flow_Informa

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Supplemental Cash Flow Information	'
	Supplemental Cash Flow Information
	The following is the supplemental cash flow information for the nine months ended September 30, 2014 and 2013 (in thousands):
		Nine Months Ended September 30,
		2014		2013
	Interest paid	$	29,758	$	27,743
	Income taxes paid	757		904
	Supplemental Disclosure of Noncash Activities:
	The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisitions:
	Debt and interest rate swaps	$	88,845	$	17,982
	Financing Activities:
	Dividend distributions declared, but not paid	$	34,652	$	34,238

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data	'
	Interim Unaudited Financial Data
	Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2013 Annual Report on Form 10-K.
Variable Interest Entities	'
	Variable Interest Entities
	As of September 30, 2014, our condensed consolidated financial statements include four VIEs, which we were deemed to be the primary beneficiary. All of the VIEs were established during the third quarter of 2014 to facilitate potential Section 1031 Exchanges.
Noncontrolling Interests	'
	Noncontrolling Interests
	HTA’s net income attributable to noncontrolling interests in the accompanying condensed consolidated statements of operations relate to both noncontrolling interest reflected within equity and redeemable noncontrolling interest of limited partners reflected outside of equity in the accompanying condensed consolidated balance sheets. Limited partner units, including LTIP awards, are accounted for as partners’ capital in HTALP’s accompanying condensed consolidated balance sheets and as noncontrolling interest reflected within equity or redeemable noncontrolling interest of limited partners reflected outside of equity in HTA’s accompanying condensed consolidated balance sheets.
	Redeemable noncontrolling interests relate to the interests in our consolidated entities that are not wholly owned by us. As these redeemable noncontrolling interests provide for redemption features not solely within our control, we classify such interests outside of permanent equity or partners’ capital.
Recently Issued or Adopted Accounting Pronouncements	'
	Recently Issued or Adopted Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Updated (“ASU”) 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) which changes the requirements for reporting discontinued operations. ASU 2014-08 changes the threshold for disclosing discontinued operations and the related disclosure requirements. Pursuant to ASU 2014-08, only disposals representing a strategic shift, such as a major line of business, a major geographical area or majority equity investment, should be presented as a discontinued operation. If the disposal does qualify as a discontinued operation under ASU 2014-08, the entity will be required to provide expanded disclosures. The guidance will be applied prospectively to new disposals and new classifications of disposal groups held for sale after the effective date. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014 with early adoption permitted but only for disposals or classifications as held for sale which have not been reported in financial statements previously issued or available for issuance. We adopted ASU 2014-08 as of January 1, 2014 and believe future sales of our individual operating properties will no longer qualify as discontinued operations.
	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. ASU 2014-09 is effective for the first interim period within annual reporting periods beginning after December 15, 2016, and early adoption is not permitted. We are still evaluating the impact of adopting ASU 2014-09 on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, Compensation - Stock Compensation (Topic 718). ASU 2014-12 requires that a performance target requisite service period be treated as a performance condition and, as a result, this type of performance condition may delay expense recognition until achievement of the performance target is probable. ASU 2014-12 is effective for reporting periods beginning after December 15, 2015, and early adoption is permitted. We will adopt ASU 2014-12 effective January 1, 2016 and it is not anticipated to have a material impact on our financial statements.

Business_Combinations_Tables

Business Combinations (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Schedule of Purchase Price Allocation	'
	The acquisitions completed during the nine months ended September 30, 2013 were determined to be individually not significant, but material on a collective basis. The allocations for these acquisitions are set forth below in the aggregate (in thousands):
	2013 Acquisitions	Total
	Land	$	13,415
	Building and improvements	175,039
	Below market leasehold interests	1,836
	Above market leases	1,987
	In place leases	32,205
	Tenant relationships	16,541
	Below market leases	(1,167		)
	Above market debt	(241		)
	Net assets acquired	239,615
	Other, net	2,299
	Aggregate purchase price	$	241,914
	Since the acquisitions were determined to be individually not significant, but material on a collective basis, the allocations for the 2014 acquisitions are set forth below in the aggregate (in thousands):
	2014 Acquisitions	Total
	Land	$	70,609
	Building and improvements	227,458
	Below market leasehold interests	98
	Above market leases	1,708
	In place leases	22,233
	Below market leases	(953		)
	Above market debt, net	(2,664		)
	Net assets acquired	318,489
	Other, net	(939		)
	Aggregate purchase price	$	317,550

Intangibles_Assets_and_Liabili1

Intangibles Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Identified Intangibles, Net [Abstract]	'
Schedule of Identified Intangible Assets and Liabilities, Net	'
	Intangible assets and liabilities consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands, except weighted average remaining amortization period):
		September 30, 2014					December 31, 2013
		Balance			Weighted Average Remaining Amortization Period in Years		Balance				Weighted Average Remaining Amortization Period in Years	Balance Sheet Classification
	Assets:
	In place leases	$	225,023		8.6		$	213,338			8.8	Lease intangibles
	Tenant relationships	188,380			10.4		198,519				10.5	Lease intangibles
	Above market leases	26,566			5.8		26,799				6.3	Other intangibles, net
	Below market leasehold interests	31,393			67.7		37,640				68.9	Other intangibles, net
		471,362					476,296
	Accumulated amortization	(172,708		)			(151,860		)
	Total	$	298,654		15.4		$	324,436			15.9
	Liabilities:
	Below market leases	$	13,999		12.1		$	13,989			12.4	Intangible liabilities, net
	Above market leasehold interests	3,827			32.4		3,827				33.1	Intangible liabilities, net
		17,826					17,816
	Accumulated amortization	(6,306		)			(6,019		)
	Total	$	11,520		18.1		$	11,797			18.4
Summary of Intangible Asset and Liabilities Amortization	'
	The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended September 30,							Nine Months Ended September 30,
		2014			2013				2014			2013
	Amortization recorded against rental income related to above or below market leases	$	505		$	417			$	1,534		$	1,298
	Rental expense related to above or below market leasehold interests	112			89				358			278
	Amortization expense related to in place leases and tenant relationships	12,066			9,955				36,247			29,970

Receivables_and_Other_Assets_T

Receivables and Other Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Receivables and Other Assets [Abstract]	'
Schedule of Receivables and Other Assets	'
	Receivables and other assets consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands):
		September 30, 2014		December 31, 2013
	Accounts and other receivables, net	$	23,749	$	22,847
	Tenant note receivable	3,080		3,173
	Deferred financing costs, net	12,418		10,921
	Deferred leasing costs, net	16,616		13,500
	Lease inducements, net	807		771
	Straight-line rent receivables, net	54,057		47,317
	Prepaid expenses, deposits, equipment and other, net	27,544		6,683
	Derivative financial instruments - interest rate swaps	3,290		5,073
	Total	$	141,561	$	110,285
Schedule of Receivables and Other Assets Amortization Expense	'
	The following is a summary of amortization of deferred leasing costs, deferred financing costs, and lease inducements for the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Amortization expense related to deferred leasing costs	$	957	$	686	$	2,646	$	1,862
	Interest expense related to deferred financing costs	724		805		2,319		3,084
	Amortization recorded against rental income related to lease inducements	50		56		168		173

Debt_Tables

Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt	'
	Debt consisted of the following as of September 30, 2014 and December 31, 2013 (in thousands):
		September 30, 2014			December 31, 2013
	Unsecured revolving credit facility	$	35,000		$	55,000
	Unsecured term loans	455,000			455,000
	Unsecured senior notes	600,000			300,000
	Fixed rate mortgages	379,196			373,751
	Variable rate mortgages	29,590			29,925
		1,498,786			1,213,676
	Net premium (discount)	(1,650		)	565
	Total	$	1,497,136		$	1,214,241
Schedule of Maturities of Long-term Debt	'
	The following table summarizes the debt maturities and scheduled principal repayments as of September 30, 2014 (in thousands):
	Year	Amount
	2014	$	2,105
	2015	73,454
	2016	104,625
	2017	102,744
	2018	314,881
	Thereafter	900,977
	Total	$	1,498,786

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2014 (in thousands):
	Notional Amount			Index		Rate			Fair Value				Instrument		Maturity
	$	200,000		LIBOR		1.23	%		$	(1,404	)		Swap		3/29/17
	100,000			LIBOR		0.86			(465		)		Swap		6/15/16
	50,000			LIBOR		1.39			812				Swap		7/17/19
	105,000			LIBOR		1.24			2,478				Swap		7/17/19
	27,062			LIBOR		4.98			(2,258		)		Swap		5/1/20
	The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2013 (in thousands):
	Notional Amount			Index		Rate			Fair Value				Instrument		Maturity
	$	200,000		LIBOR		1.23	%		$	(2,078	)		Swap		3/29/17
	100,000			LIBOR		0.86			(729		)		Swap		6/15/16
	50,000			LIBOR		1.39			1,350				Swap		7/17/19
	105,000			LIBOR		1.24			3,723				Swap		7/17/19
	27,618			LIBOR		4.98			(2,246		)		Swap		5/1/20
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location	'
	As of September 30, 2014 and December 31, 2013, the gross fair value of our derivative financial instruments was as follows (in thousands):
			Asset Derivatives									Liability Derivatives
				Fair Value										Fair Value
	Derivatives Not Designated as Hedging Instruments:		Balance Sheet	30-Sep-14				31-Dec-13				Balance Sheet		30-Sep-14			31-Dec-13
			Location									Location
	Interest rate swaps		Receivables and other assets	$	3,290			$	5,073			Derivative financial instruments		$	4,127		$	5,053
	There were no derivatives offset in our accompanying condensed consolidated balance sheets as of September 30, 2014 and December 31, 2013. As of September 30, 2014 and December 31, 2013, we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands):
		30-Sep-14											31-Dec-13
		Gross Amounts			Amounts Subject to Enforceable Master Netting Arrangements				Net Amounts				Gross Amounts			Amounts Subject to Enforceable Master Netting Arrangements			Net Amounts
	Asset derivatives	$	3,290		$	(1,404	)		$	1,886			$	5,073		$	(2,078	)	$	2,995
	Liability derivatives	4,127			(1,404		)		2,723				5,053			(2,078		)	2,975

Stockholders_Equity_and_Partne1

Stockholders' Equity and Partners' Capital (Tables)	9 Months Ended
	Sep. 30, 2014
LTIP	'
Class of Stock	'
Schedule of Nonvested Share Activity	'
	The following is a summary of the activity in our LTIP units during 2014:
		LTIP Units		Weighted
				Average Grant
				Date Fair Value
	Balance as of December 31, 2013	516,500		$	9.43
	Granted	—		—
	Vested	—		—
	Forfeited	(6,020	)	5.62
	Balance as of September 30, 2014	510,480		$	9.47
Restricted Stock	'
Class of Stock	'
Schedule of Nonvested Share Activity	'
	The following is a summary of the activity in our restricted common stock during 2014:
		Restricted Common Stock		Weighted
				Average Grant
				Date Fair Value
	Balance as of December 31, 2013	641,000		$	10.34
	Granted	563,200		10.21
	Vested	(148,000	)	10.07
	Forfeited	(55,600	)	9.96
	Balance as of September 30, 2014	1,000,600		$	10.46

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'
	The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2014, aggregated by the applicable Level in the fair value hierarchy (in thousands):
			Quoted Prices in			Significant Other			Significant			Total
			Active Markets for			Observable Inputs			Unobservable Inputs
			Identical Assets			(Level 2)			(Level 3)
			and Liabilities
			(Level 1 )
	Assets:
	Derivative financial instruments		$	—		$	3,290		$	—		$	3,290
	Liabilities:
	Derivative financial instruments		$	—		$	4,127		$	—		$	4,127
	The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2013, aggregated by the applicable Level in the fair value hierarchy (in thousands):
			Quoted Prices in			Significant Other			Significant			Total
			Active Markets for			Observable Inputs			Unobservable Inputs
			Identical Assets			(Level 2)			(Level 3)
			and Liabilities
			(Level 1 )
	Assets:
	Derivative financial instruments		$	—		$	5,073		$	—		$	5,073
	Liabilities:
	Derivative financial instruments		$	—		$	5,053		$	—		$	5,053
Schedule of Fair Value of Financial Instruments	'
	The following table sets forth the carrying value and fair value of our real estate notes receivable, tenant note receivable and debt (in thousands):
				September 30, 2014						December 31, 2013
		Fair Value Level		Carrying Amount			Fair Value			Carrying Amount			Fair Value
	Real estate notes receivable	2		$	8,520		$	8,520		$	28,520		$	28,520
	Tenant note receivable	2		3,080			3,028			3,173			3,013
	Debt	2		1,497,136			1,509,761			1,214,241			1,237,699

Per_Share_Data_of_HTA_Tables

Per Share Data of HTA (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA common stock for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Numerator:
	Net income	$	16,220		$	5,005		$	24,537		$	20,622
	Net income attributable to noncontrolling interests	(188		)	(182		)	(358		)	(423		)
	Net income attributable to common stockholders	$	16,032		$	4,823		$	24,179		$	20,199
	Denominator:
	Weighted average number of shares outstanding - basic	238,968			232,514			238,099			225,132
	Dilutive shares	2,464			2,509			2,509			1,639
	Weighted average number of shares outstanding - diluted	241,432			235,023			240,608			226,771
	Earnings per common share - basic
	Net income attributable to common stockholders	$	0.07		$	0.02		$	0.1		$	0.09
	Earnings per common share - diluted
	Net income attributable to common stockholders	$	0.07		$	0.02		$	0.1		$	0.09

Per_Unit_Data_of_HTALP_Tables

Per Unit Data of HTALP (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Unit, Basic and Diluted	'
	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per unit data):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Numerator:
	Net income	$	16,220		$	5,005		$	24,537		$	20,622
	Net income attributable to noncontrolling interests	(28		)	(9		)	(106		)	(39		)
	Net income attributable to common unitholders	$	16,192		$	4,996		$	24,431		$	20,583
	Denominator:
	Weighted average number of units outstanding - basic	241,948			235,570			241,124			228,188
	Dilutive units	—			—			—			—
	Weighted average number of units outstanding - diluted	241,948			235,570			241,124			228,188
	Earnings per common unit - basic:
	Net income attributable to common unitholders	$	0.07		$	0.02		$	0.1		$	0.09
	Earnings per common unit - diluted:
	Net income attributable to common unitholders	$	0.07		$	0.02		$	0.1		$	0.09

Supplemental_Cash_Flow_Informa1

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Schedule of Cash Flow, Supplemental Disclosures	'
	The following is the supplemental cash flow information for the nine months ended September 30, 2014 and 2013 (in thousands):
		Nine Months Ended September 30,
		2014		2013
	Interest paid	$	29,758	$	27,743
	Income taxes paid	757		904
	Supplemental Disclosure of Noncash Activities:
	The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisitions:
	Debt and interest rate swaps	$	88,845	$	17,982
	Financing Activities:
	Dividend distributions declared, but not paid	$	34,652	$	34,238

Organization_and_Description_o1

Organization and Description of Business (Details) (USD $)	9 Months Ended
In Billions, unless otherwise specified	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
General partnership interest percentage	99.00%
Purchased property inception to current date	$3.30

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Accounting Policies [Abstract]	'	'	'	'
Number of VIEs	4	'	4	'
Increase in real estate assets as a result of consolidating the VIEs	$72.20	'	$72.20	'
Building and Improvements	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Depreciation expense	$22.60	$18.90	$65	$55.60

Business_Combinations_Details

Business Combinations (Details) (USD $)	9 Months Ended		1 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014	Jun. 30, 2014	Aug. 31, 2014	Aug. 31, 2014	Sep. 30, 2014
	acquisition		Medical Office Buildings in Boston, MA, Miami, FL and Baltimore, MD	Medical Office Building in Raleigh, North Carolina	Medical Office Buildings in White Plains, New York	Medical Office Building in Charleston, South Carolina	Medical Office Building in Clearwater, Florida
Business Acquisition [Line Items]	'	'	'	'	'	'	'
Number of acquisitions	5	'	'	'	'	'	'
Closing costs	$5,600,000	'	'	'	'	'	'
Mortgage loans assumed	91,500,000	'	'	'	'	'	'
Business Acquisition, Purchase Price Allocation, Real Estate [Abstract]	'	'	'	'	'	'	'
Land	70,609,000	13,415,000	'	'	'	'	'
Building and improvements	227,458,000	175,039,000	'	'	'	'	'
Below market leasehold interests	98,000	1,836,000	'	'	'	'	'
Above market leases	1,708,000	1,987,000	'	'	'	'	'
In place leases	22,233,000	32,205,000	'	'	'	'	'
Tenant relationships	'	16,541,000	'	'	'	'	'
Below market leases	-953,000	-1,167,000	'	'	'	'	'
Above market debt, net	-2,664,000	-241,000	'	'	'	'	'
Net assets acquired	318,489,000	239,615,000	'	'	'	'	'
Other, net	-939,000	2,299,000	'	'	'	'	'
Aggregate purchase price	$317,550,000	$241,914,000	$200,000,000	$11,500,000	$64,000,000	$24,800,000	$17,300,000
Weighted average lives of acquired intangible assets	'9 years 1 month 10 days	'7 years 4 months 18 days	'	'	'	'	'
Weighted average lives of acquired intangible liabilities	'8 years 5 months 16 days	'5 years 8 months 18 days	'	'	'	'	'

Dispositions_and_Assets_Held_f1

Dispositions and Assets Held for Sale (Details) (USD $)	3 Months Ended			9 Months Ended					1 Months Ended
	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Oct. 29, 2014
	building					property	Assets Held-for-sale, Real Estate Investments	Assets Held-for-sale, Other Intangibles	Subsequent Event
Long Lived Assets Held-for-sale [Line Items]	'	'	'	'	'	'	'	'	'
Number of dispositions of portfolios of medical office buildings	2	'	'	'	'	'	'	'	'
Aggregate gross sales price of disposed portfolios of medical office buildings	$42,000,000	'	'	'	'	'	'	'	'
Gain from sale of disposed portfolios of medical office buildings	11,766,000	'	0	11,766,000	0	'	'	'	16,000,000
Gross proceeds from sale of property	40,900,000	'	'	'	'	'	'	'	'
Assets held for sale, net	22,930,000	'	'	22,930,000	'	0	18,900,000	3,100,000	'
Number of properties held-for-sale	'	'	'	'	'	1	'	'	'
Depreciation expense on reclassified assets	'	$800,000	'	'	'	'	'	'	'

Real_Estate_Notes_Receivable_D

Real Estate Notes Receivable (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
	promissory_notes
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'
Total real estate notes receivable	$8,500,000	'	$28,500,000
Collection of real estate notes receivable	$20,000,000	$0	'
Number of promissory notes secured by office buildings	2	'	'
Portfolio One	'	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'
Interest rate	7.00%	'	'
Portfolio Two	'	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'
Interest rate	7.00%	'	'

Intangibles_Assets_and_Liabili2

Intangibles Assets and Liabilities (Details) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Assets	'	'
Gross	$471,362	$476,296
Accumulated amortization	-172,708	-151,860
Total	298,654	324,436
Weighted average remaining amortization period in years	'15 years 4 months 24 days	'15 years 10 months 24 days
Liabilities	'	'
Gross	17,826	17,816
Accumulated amortization	-6,306	-6,019
Total	11,520	11,797
Weighted average remaining amortization period in years	'18 years 1 month 6 days	'18 years 4 months 24 days
Below Market Leases	'	'
Liabilities	'	'
Gross	13,999	13,989
Weighted average remaining amortization period in years	'12 years 1 month 6 days	'12 years 4 months 24 days
Above Market Leasehold Interests	'	'
Liabilities	'	'
Gross	3,827	3,827
Weighted average remaining amortization period in years	'32 years 4 months 24 days	'33 years 1 month 6 days
In Place Leases	'	'
Assets	'	'
Gross	225,023	213,338
Weighted average remaining amortization period in years	'8 years 7 months 6 days	'8 years 9 months 18 days
Tenant Relationships	'	'
Assets	'	'
Gross	188,380	198,519
Weighted average remaining amortization period in years	'10 years 4 months 24 days	'10 years 6 months
Above Market Leases	'	'
Assets	'	'
Gross	26,566	26,799
Weighted average remaining amortization period in years	'5 years 9 months 18 days	'6 years 3 months 18 days
Below Market Leasehold Interests	'	'
Assets	'	'
Gross	$31,393	$37,640
Weighted average remaining amortization period in years	'67 years 8 months 12 days	'68 years 10 months 24 days

Intangibles_Assets_and_Liabili3

Intangibles Assets and Liabilities - Summary of Intangible Amortization (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Amortization recorded against rental income related to above or below market leases	'	'	'	'
Finite-Lived Intangibles	'	'	'	'
Amortization of intangible assets and liabilities	$505	$417	$1,534	$1,298
Rental expense related to above or below market leasehold interests	'	'	'	'
Finite-Lived Intangibles	'	'	'	'
Amortization of intangible assets and liabilities	112	89	358	278
Amortization expense related to in place leases and tenant relationships	'	'	'	'
Finite-Lived Intangibles	'	'	'	'
Amortization of intangible assets and liabilities	$12,066	$9,955	$36,247	$29,970

Receivables_and_Other_Assets_D

Receivables and Other Assets (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Receivables and Other Assets [Abstract]	'	'	'	'	'
Accounts and other receivables, net	$23,749	'	$23,749	'	$22,847
Tenant note receivable	3,080	'	3,080	'	3,173
Deferred financing costs, net	12,418	'	12,418	'	10,921
Deferred leasing costs, net	16,616	'	16,616	'	13,500
Lease inducements, net	807	'	807	'	771
Straight-line rent receivables, net	54,057	'	54,057	'	47,317
Prepaid expenses, deposits, equipment and other, net	27,544	'	27,544	'	6,683
Derivative financial instruments - interest rate swaps	3,290	'	3,290	'	5,073
Total	141,561	'	141,561	'	110,285
Amortization expense related to deferred leasing costs	957	686	2,646	1,862	'
Interest expense related to deferred financing costs	724	805	2,319	3,084	'
Amortization recorded against rental income related to lease inducements	$50	$56	$168	$173	'

Debt_Net_Details

Debt - Net (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument	'	'
Total debt, gross	$1,498,786	$1,213,676
Net premium (discount)	-1,650	565
Total	1,497,136	1,214,241
Unsecured Term Loans	'	'
Debt Instrument	'	'
Total debt, gross	455,000	455,000
Unsecured Senior Notes	'	'
Debt Instrument	'	'
Total debt, gross	600,000	300,000
Mortgages | Fixed Rate Mortgages	'	'
Debt Instrument	'	'
Total debt, gross	379,196	373,751
Mortgages | Variable Rate Mortgages	'	'
Debt Instrument	'	'
Total debt, gross	29,590	29,925
Unsecured Revolving Credit Facility	'	'
Debt Instrument	'	'
Line of credit facility, amount outstanding	$35,000	$55,000

Debt_Principal_Maturity_Schedu

Debt - Principal Maturity Schedule (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'	'
2014	$2,105	'
2015	73,454	'
2016	104,625	'
2017	102,744	'
2018	314,881	'
Thereafter	900,977	'
Total	$1,498,786	$1,213,676

Debt_Textuals_Details

Debt - Textuals (Details) (USD $)

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

9 Months Ended

Jan. 07, 2014

Sep. 30, 2014

Jan. 07, 2014

Jan. 07, 2014

Jan. 07, 2014

Sep. 30, 2014

Jul. 20, 2012

Jul. 20, 2012

Jul. 20, 2012

Mar. 28, 2013

Jun. 26, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Term Loans

Unsecured Senior Notes

Unsecured Senior Notes

Mortgages

Mortgages

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

Unsecured Revolving Credit Facility

$300.0 Million Unsecured Term Loan

$300.0 Million Unsecured Term Loan

$300.0 Million Unsecured Term Loan

$300.0 Million Unsecured Term Loan

$300.0 Million Unsecured Term Loan

$155.0 Million Unsecured Term Loan

$155.0 Million Unsecured Term Loan

$155.0 Million Unsecured Term Loan

$155.0 Million Unsecured Term Loan

Unsecured Senior Notes Due 2023

Unsecured Senior Notes Due 2021

Variable Rate Mortgages

Minimum

Maximum

Minimum

Maximum

Minimum

Maximum

Debt Instrument

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit facility, borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

$650,000,000

'

'

Unsecured credit agreement, extension option period

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

Description of variable rate basis

'LIBOR

'

'

'

'

'

'

'

'

'

'

'

'

'LIBOR

'

'

Basis spread on variable rate

'

1.20%

'

1.05%

1.95%

1.70%

'

1.55%

2.40%

'

'

'

'

1.30%

1.10%

1.75%

Line of credit facility, commitment fee percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

0.20%

0.50%

Debt instrument, face amount

'

'

$300,000,000

'

'

'

$155,000,000

'

'

$300,000,000

$300,000,000

'

'

'

'

'

Weighted average interest rate with interest rate swap impact

'

2.30%

'

'

'

2.99%

'

'

'

'

'

'

5.56%

'

'

'

Debt instrument, stated interest rate

'

'

'

'

'

'

'

'

'

3.70%

3.38%

'

'

'

'

'

Debt instrument, percentage of principal amount received

'

'

'

'

'

'

'

'

'

99.19%

99.21%

'

'

'

'

'

Debt instrument, effective interest rate

'

'

'

'

'

'

'

'

'

3.80%

3.50%

'

'

'

'

'

Effective percentage rate range, minimum

'

'

'

'

'

'

'

'

'

'

'

1.60%

'

'

'

'

Effective percentage rate range, maximum

'

'

'

'

'

'

'

'

'

'

'

12.75%

'

'

'

'

Weighted average interest rate

'

'

'

'

'

'

'

'

'

'

'

5.31%

'

'

'

'

Derivative_Financial_Instrumen2

Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Derivative	'	'
Fair value, liability	($4,127)	($5,053)
Fair value, asset	3,290	5,073
Interest Rate Swap | 1.23%	'	'
Derivative	'	'
Notional Amount	200,000	200,000
Index	'LIBOR	'LIBOR
Rate	1.23%	1.23%
Fair value, liability	-1,404	-2,078
Interest Rate Swap | 0.86%	'	'
Derivative	'	'
Notional Amount	100,000	100,000
Index	'LIBOR	'LIBOR
Rate	0.86%	0.86%
Fair value, liability	-465	-729
Interest Rate Swap | 1.39%	'	'
Derivative	'	'
Notional Amount	50,000	50,000
Index	'LIBOR	'LIBOR
Rate	1.39%	1.39%
Fair value, asset	812	1,350
Interest Rate Swap | 1.24%	'	'
Derivative	'	'
Notional Amount	105,000	105,000
Index	'LIBOR	'LIBOR
Rate	1.24%	1.24%
Fair value, asset	2,478	3,723
Interest Rate Swap | 4.98%	'	'
Derivative	'	'
Notional Amount	27,062	27,618
Index	'LIBOR	'LIBOR
Rate	4.98%	4.98%
Fair value, liability	($2,258)	($2,246)

Derivative_Financial_Instrumen3

Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivatives, Fair Value	'	'
Derivative financial instruments, asset	$3,290	$5,073
Derivative financial instruments, liability	4,127	5,053
Interest Rate Swap | Not Designated as Hedging Instrument | Receivables and Other Assets	'	'
Derivatives, Fair Value	'	'
Derivative financial instruments, asset	3,290	5,073
Interest Rate Swap | Not Designated as Hedging Instrument | Derivative Financial Instruments	'	'
Derivatives, Fair Value	'	'
Derivative financial instruments, liability	$4,127	$5,053

Derivative_Financial_Instrumen4

Derivative Financial Instruments - Derivative Offsetting (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Derivative financial instruments, asset	$3,290	$5,073
Derivative assets, amounts subject to enforceable master netting arrangements	-1,404	-2,078
Derivative assets, net amounts	1,886	2,995
Derivative liabilities	4,127	5,053
Derivative liabilities, amounts subject to enforceable master netting arrangements	-1,404	-2,078
Derivative liabilities, net amounts	$2,723	$2,975

Stockholders_Equity_and_Partne2

Stockholders' Equity and Partners' Capital (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2014

Oct. 28, 2014

Sep. 30, 2014

Feb. 28, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2013

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Listing Expenses

General and Administrative Expense

General and Administrative Expense

2006 Incentive Plan

Subsequent Event

Common Stock Offering

Common Stock Offering

LTIP

LTIP

LTIP

Restricted Common Stock

Restricted Common Stock

Restricted Common Stock

Maximum

Listing Expenses

Listing Expenses

Common Stock Offerings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum amount of common stock authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

$300,000,000

'

'

'

Issuance of common stock (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

1,541,715

'

'

'

'

Stock issued, average price per share (in usd per share)

'

'

'

'

'

'

'

'

'

'

'

'

$11.86

'

'

'

'

Remaining available amount of common stock for issuance

'

'

'

'

'

'

'

'

'

'

'

'

281,700,000

'

'

'

'

Common Stock Dividends

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends declared per common share (in usd per share)

$0.15

$0.14

$0.43

$0.43

'

'

'

'

'

'

'

$0.14

'

'

'

'

'

Incentive Plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares authorized

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

'

'

'

Number of shares available for grant

'

'

'

'

'

'

'

'

'

'

4,594,200

'

'

'

'

'

'

Allocated share-based compensation expense

'

'

'

'

1,000,000

3,300,000

2,000,000

600,000

500,000

1,400,000

'

'

'

'

'

0

3,100,000

Nonvested awards, total compensation cost not yet recognized

'

'

'

'

$5,200,000

$5,200,000

'

'

'

'

'

'

'

'

$4,500,000

'

'

Contingent units

'

'

'

'

'

'

'

'

'

'

'

'

'

'

450,000

'

'

Period for recognition

'

'

'

'

'

'2 years

'

'

'

'

'

'

'

'

'

'

'

Stockholders_Equity_and_Partne3

Stockholders' Equity and Partners' Capital - Nonvested Rollforward (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
LTIP	'
Stocks/Units:	'
Balance as of beginning of period (in shares)	516,500
Granted (in shares)	0
Vested (in shares)	0
Forfeited (in shares)	-6,020
Balance as of end of period (in shares)	510,480
Weighted Average Grant Date Fair Value:	'
Balance as of beginning of period (in usd per share)	$9.43
Granted (in usd per share)	$0
Vested (in usd per share)	$0
Forfeited (in usd per share)	$5.62
Balance as of end of period (in usd per share)	$9.47
Restricted Stock	'
Stocks/Units:	'
Balance as of beginning of period (in shares)	641,000
Granted (in shares)	563,200
Vested (in shares)	-148,000
Forfeited (in shares)	-55,600
Balance as of end of period (in shares)	1,000,600
Weighted Average Grant Date Fair Value:	'
Balance as of beginning of period (in usd per share)	$10.34
Granted (in usd per share)	$10.21
Vested (in usd per share)	$10.07
Forfeited (in usd per share)	$9.96
Balance as of end of period (in usd per share)	$10.46

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Derivative financial instruments, asset	$3,290	$5,073
Derivative financial instruments, liability	4,127	5,053
Fair Value, Measurements, Recurring	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Derivative financial instruments, asset	3,290	5,073
Derivative financial instruments, liability	4,127	5,053
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1 )	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Derivative financial instruments, asset	0	0
Derivative financial instruments, liability	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Derivative financial instruments, asset	3,290	5,073
Derivative financial instruments, liability	4,127	5,053
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Derivative financial instruments, asset	0	0
Derivative financial instruments, liability	$0	$0

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Real estate notes receivable	$8,520	$28,520
Tenant note receivable	3,080	3,173
Debt	1,497,136	1,214,241
Fair Value Level 2 | Carrying Amount	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Real estate notes receivable	8,520	28,520
Tenant note receivable	3,080	3,173
Debt	1,497,136	1,214,241
Fair Value Level 2 | Fair Value	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Real estate notes receivable	8,520	28,520
Tenant note receivable	3,028	3,013
Debt	$1,509,761	$1,237,699

Per_Share_Data_of_HTA_Details

Per Share Data of HTA (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Numerator:	'		'		'		'
Net income	$16,220		$5,005		$24,537		$20,622
Net income attributable to noncontrolling interests	-188	[1]	-182	[1]	-358	[1]	-423	[1]
Net income attributable to common stockholders/unitholders	$16,032		$4,823		$24,179		$20,199
Denominator:	'		'		'		'
Weighted average number of shares/units outstanding — basic	238,968		232,514		238,099		225,132
Dilutive shares	2,464		2,509		2,509		1,639
Weighted average number of shares/units outstanding — diluted	241,432		235,023		240,608		226,771
Earnings per common share - basic	'		'		'		'
Net income attributable to common stockholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Earnings per common share - diluted	'		'		'		'
Net income attributable to common stockholders (usd per share)	$0.07		$0.02		$0.10		$0.09
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Per_Unit_Data_of_HTALP_Details

Per Unit Data of HTALP (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Numerator:	'		'		'		'
Net income	$16,220		$5,005		$24,537		$20,622
Net income attributable to noncontrolling interests	-188	[1]	-182	[1]	-358	[1]	-423	[1]
Net income attributable to common stockholders/unitholders	16,032		4,823		24,179		20,199
Denominator:	'		'		'		'
Weighted average number of shares/units outstanding — basic	238,968		232,514		238,099		225,132
Dilutive units	2,464		2,509		2,509		1,639
Weighted average number of shares/units outstanding — diluted	241,432		235,023		240,608		226,771
Earnings per common unit - basic:	'		'		'		'
Net income attributable to common unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Earnings per common unit - diluted:	'		'		'		'
Net income attributable to common unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Healthcare Trust of America Holdings, LP (HTALP)	'		'		'		'
Numerator:	'		'		'		'
Net income	16,220		5,005		24,537		20,622
Net income attributable to noncontrolling interests	-28	[1]	-9	[1]	-106	[1]	-39	[1]
Net income attributable to common stockholders/unitholders	$16,192		$4,996		$24,431		$20,583
Denominator:	'		'		'		'
Weighted average number of shares/units outstanding — basic	241,948		235,570		241,124		228,188
Dilutive units	0		0		0		0
Weighted average number of shares/units outstanding — diluted	241,948		235,570		241,124		228,188
Earnings per common unit - basic:	'		'		'		'
Net income attributable to common unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
Earnings per common unit - diluted:	'		'		'		'
Net income attributable to common unitholders (usd per share)	$0.07		$0.02		$0.10		$0.09
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Supplemental_Cash_Flow_Informa2

Supplemental Cash Flow Information (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Supplemental Disclosure of Cash Flow Information:	'	'
Interest paid	$29,758	$27,743
Income taxes paid	757	904
The following represents the significant increase (decrease) in certain assets and liabilities in connection with our acquisitions:	'	'
Debt and interest rate swaps	88,845	17,982
Financing Activities:	'	'
Dividend distributions declared, but not paid	$34,652	$34,238